Global Diabetes Treatment Medical Devices Market Growth (Status and Outlook) 2024-2030

Global Diabetes Treatment Medical Devices Market Growth (Status and Outlook) 2024-2030

This report focus on Diabetes Treatment Medical Devices market. Injection Pens - Injection pens are used for injecting a drug in a patient-friendly way that is easier than using a syringe. Insulin Pumps - Insulin pumps are devices that deliver insulin without the need for manual injections. Automated Insulin Delivery Systems (Artificial Pancreas, Closed Loop) - The development of automated insulin delivery has many names – artificial pancreas, hybrid closed loop, bionic pancreas – but all share the same goal: using continuous glucose monitors (CGM) and smart algorithms that automatically adjust insulin delivery via pump. The goal of these products is to reduce or eliminate hypoglycemia, improve time in range, and reduce hyperglycemia – especially overnight.

The global Diabetes Treatment Medical Devices market size is projected to grow from US$ 18390 million in 2023 to US$ 43770 million in 2030; it is expected to grow at a CAGR of 13.2% from 2024 to 2030.

LPI (LP Information)' newest research report, the “Diabetes Treatment Medical Devices Industry Forecast” looks at past sales and reviews total world Diabetes Treatment Medical Devices sales in 2023, providing a comprehensive analysis by region and market sector of projected Diabetes Treatment Medical Devices sales for 2024 through 2030. With Diabetes Treatment Medical Devices sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Diabetes Treatment Medical Devices industry.

This Insight Report provides a comprehensive analysis of the global Diabetes Treatment Medical Devices landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Diabetes Treatment Medical Devices portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Diabetes Treatment Medical Devices market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Diabetes Treatment Medical Devices and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Diabetes Treatment Medical Devices.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

This report presents a comprehensive overview, market shares, and growth opportunities of Diabetes Treatment Medical Devices market by product type, application, key players and key regions and countries.

Segmentation by type
Insulin Pump
Insulin Injection Pen
Insulin Syringe
Others

Segmentation by application
Home Care
Hospital
Clinic

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Novo Nordisk
Eli Lilly
Medtronic
Roche
Insulet
Tandem
SOOIL
Royal Fornia Medical
Sanofi
BD
Ypsomed Holding
Dongbao Pharmaceutical

Please note: The report will take approximately 2 business days to prepare and deliver.